Xenetic Biosciences Inc (XBIO)

02:56 AM

XBIOXenetic Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

02:56 AM

09:13 AM

Xenetic presents preclinical data on DNase I with CAR T cells in murine model - TipRanks

09:13 AM

08:32 AM

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis - AccessWire

08:32 AM

08:30 AM

Xenetic Bio's DNase I + CAR T Cell Therapy Shows Breakthrough in Melanoma Treatment | XBIO Stock News - StockTitan

08:30 AM

Nov 15, 2024

Xenetic Biosciences Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024

Nov 13, 2024

Xenetic reports Q3 EPS (28c) vs. (69c) last year - TipRanks

Nov 13, 2024

Nov 13, 2024

Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results - AccessWire

Nov 13, 2024

Nov 13, 2024

Xenetic Bio Q3: R&D Costs Drop 64% as DNase Cancer Program Advances | $6.8M Cash | XBIO Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Xenetic Biosciences: Q3 Earnings Snapshot - Houston Chronicle

Nov 13, 2024

Nov 12, 2024

Xenetic presents preclinical data on DNase platform technology - TipRanks

Nov 12, 2024

Nov 12, 2024

Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models - Oil City Derrick

Nov 12, 2024

Nov 12, 2024

Xenetic's DNase I Breakthrough Boosts Cancer Immunotherapy Efficacy in Preclinical Study | XBIO Stock News - StockTitan

Nov 12, 2024

Nov 09, 2024

Xenetic Biosciences Extends Research Collaboration with The Scripps Research Institute - Defense World

Nov 09, 2024

Nov 07, 2024

Xenetic extends research collaboration with Scripps Research Institute - TipRanks

Nov 07, 2024

Nov 07, 2024

Xenetic Biosciences Expands Collaboration for Cancer Treatment - TipRanks

Nov 07, 2024

Nov 07, 2024

Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - AccessWire

Nov 07, 2024

Oct 31, 2024

Xenetic Biosciences announces board member changes - Investing.com India

Oct 31, 2024

Oct 31, 2024

Xenetic Biosciences announces board member changes By Investing.com - Investing.com UK

Oct 31, 2024

Oct 26, 2024

Short Interest in Xenetic Biosciences Inc (NASDAQ:XBIO) Grows By 460.0% - Defense World

Oct 26, 2024

Oct 22, 2024

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024 - AccessWire

Oct 22, 2024

Oct 21, 2024

SEC Form S-3 filed by Xenetic Biosciences Inc. - Quantisnow

Oct 21, 2024

Oct 17, 2024

Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform - AccessWire

Oct 17, 2024

Oct 16, 2024

Secondary Progressive Multiple Sclerosis Drug Market to Expand with Significant CAGR by 2034 |AB Science SA, Actelion Lt – IndiaPolitics.com - IndiaPolitics.com

Oct 16, 2024

Oct 13, 2024

Short Interest in Xenetic Biosciences Inc (NASDAQ:XBIO) Drops By 50.0% - Defense World

Oct 13, 2024

Sep 13, 2024

Xenetic Biosciences Inc (NASDAQ:XBIO) Sees Significant Decline in Short Interest - Defense World

Sep 13, 2024

Sep 11, 2024

Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference - Kansas City Star

Sep 11, 2024

Aug 22, 2024

Q3 2024 Earnings Estimate for Xenetic Biosciences Inc (NASDAQ:XBIO) Issued By HC Wainwright - Defense World

Aug 22, 2024

Aug 21, 2024

XBIO Stock Earnings: Xenetic Biosciences Meets EPS, Beats Revenue for Q2 2024 - MSN

Aug 21, 2024

Aug 21, 2024

Xenetic Biosciences (NASDAQ:XBIOW) Stock Price Up 33.9% - Defense World

Aug 21, 2024

Aug 20, 2024

Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 20, 2024

Aug 20, 2024

Xenetic Biosciences (NASDAQ:XBIO) Earns “Neutral” Rating from HC Wainwright - Defense World

Aug 20, 2024

Aug 18, 2024

Xenetic Biosciences Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Simply Wall St

Aug 18, 2024

Aug 16, 2024

Xenetic Biosciences (NASDAQ:XBIO) Releases Earnings Results, Hits Estimates - Defense World

Aug 16, 2024

Aug 14, 2024

Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - Markets Insider

Aug 14, 2024

Aug 14, 2024

Xenetic Biosciences: Q2 Earnings Snapshot - CTPost

Aug 14, 2024